PAO Group, Inc.

Recent News

  • PAOG Target, CBD Pharma Development, In Puerto Rico Could Get Boost From COVID-19

    Sandusky, Ohio--(Newsfile Corp. - September 17, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today highlighted recent increased interest in the resurgence of industry wide pharmaceutical research and manufacturing in Puerto Rico.Pharmaceutical ResearchTo view an enhanced version of this graphic, please visit:

    2020-09-17 11:08 AM ET
  • PAOG Announces Agreement to Build Pharmaceutical Hemp Cultivar Facility on PURA Farmersville Site

    Sandusky, Ohio--(Newsfile Corp. - September 16, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced an agreement with Puration, Inc. (OTC Pink: PURA) to build a proprietary hemp cultivar development facility on PURA's Farmersville, Texas branded site.PAOG recently acquired a hemp cultivation business from PURA and is now expanding upon that business to develop a proprietary hemp cultivar in conjunction with the company's overall pharmaceutical focus.PAOG is developing a hemp derived cannabidiol (CBD) pharmaceutical treatment for Chronic Obstructive Pulmonary...

    2020-09-16 9:13 AM ET
  • PAOG Advances RespRx Research Into International CBD Pharma Research Arena

    Sandusky, Ohio--(Newsfile Corp. - September 15, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced an international research initiative to advance its hemp derived cannabidiol (CBD) pharmaceutical treatment for Chronic Obstructive Pulmonary Disease (COPD).Cannabidiol CBD clear oil capsules and full spectrum Hemp paste on wooden tableTo view an enhanced version

    2020-09-15 3:05 PM ET
  • PAOG Goes Global with CBD Pharmaceutical Research to Target $5.8 Billion Market

    Sandusky, Ohio--(Newsfile Corp. - September 15, 2020) - PAO Group, Inc. (OTC Pink: PAOG) announces a multifold, international research initiative to advance its hemp derived cannabidiol (CBD) pharmaceutical treatment for Chronic Obstructive Pulmonary Disease (COPD).The COPD treatment, RespRx, is derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT". In an initial scientific evaluation as a treatment for COPD, RespRx has demonstrated effecting...

    2020-09-15 9:44 AM ET
  • PAOG New Updates Toward Penetrating $5.8B Cannabis Pharmaceutical Market Coming This Friday

    Sandusky, Ohio--(Newsfile Corp. - September 14, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced an interview of CEO James C. DiPrima on MoneyTV with Donald Baillargeon scheduled for release this Friday, September 18, 2020. DiPrima will discuss the company's latest CBD bio pharma developments in addition to fielding questions on the recently Goldman Small Cap Analyst Research Update that includes target pricing.Grand View Research projects that the cannabis pharmaceutical market will reach a size of $5.8 billion...

    2020-09-14 2:17 PM ET
  • PAOG Rated Bullish And Given PPS Target In Updated Analyst Report Published Today

    Sandusky, Ohio--(Newsfile Corp. - September 8, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced Goldman Small Cap Research has published an analyst research report update. PAOG has recently entered the cannabis biopharmaceutical sector through two recent acquisitions. The company acquired a cannabis cultivation business from Puration, Inc. (PURA). From Kali-Extracts (KALY), PAOG acquired a proprietary CBD extract derived from a patented extraction process and formulated for the treatment of respiratory disorders. PAOG's recently acquired proprietary formulations...

    2020-09-08 10:37 AM ET
  • PAOG Announces Goldman Small Cap Research Update Scheduled Next Week

    Sandusky, Ohio--(Newsfile Corp. - September 2, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced an analyst research report update form Goldman Small Cap Research scheduled to be published next week on Tuesday, September 8, 2020.The original Goldman Small Cap Research Update can be reviewed at:Under The Radar CBD Pharma Player Could Offer Major UpsidePAOG recently executed two acquisitions as part of an overall business revitalization strategy bringing the company into the cannabis biopharmaceutical sector. The company acquired a...

    2020-09-02 1:20 PM ET
  • PAOG Completes Compliance Updates In Conjunction With Cannabis Biopharma Revitalization Initiative

    Sandusky, Ohio--(Newsfile Corp. - August 27, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced having published all required filings necessary to meet the OTC Markets "Current Information" reporting standard. Yesterday, the company published the final compliance requirement, a legal opinion, following the publications of its Q1 2020 and Q2 2020 report earlier this week and the 2019 annual report published late last week. The company anticipates the "Current Information" status to soon be reflected on the OTC...

    2020-08-27 9:14 AM ET